Chronic Kidney Disease(CKD) Clinical Trial
Official title:
Medication Adherence Given Individual SystemCHANGE(TM) in Advancing Nephropathy (MAGICIAN) Pilot Study
The purpose of this 2-group, randomized, controlled trial is to evaluate the refined SystemCHANGE™ against attention control patient education in CKD patients taking RAAS medications.
In this study, the investigators will test a refined SystemCHANGE™ in patients taking RAAS inhibiting medications. Participants will be recruited from two sources: 1) the largest and most comprehensive health care system in the state and 2) one of the largest essential health care systems in the country. Data are collected at baseline, 8 weeks (immediately post-intervention), and 12 weeks. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04579315 -
Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease
|
N/A | |
| Recruiting |
NCT05732727 -
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
|
Phase 3 | |
| Active, not recruiting |
NCT02165878 -
KoreaN Cohort Study for Outcome in Pediatric Patients With Chronic Kidney Disease
|
||
| Completed |
NCT01227616 -
Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis
|
Phase 4 | |
| Not yet recruiting |
NCT06344936 -
Drug-drug Interaction Study of HRS-1780 Tablets in Healthy Subjects
|
Phase 1 |